Organon & Co. (OGN)
NYSE: OGN · Real-Time Price · USD
13.74
+0.04 (0.26%)
Sep 23, 2026, 2:05 PM EDT - Market open
Organon & Co. Market Cap
Organon & Co. has a market cap or net worth of $3.61 billion as of September 23, 2026. Its market cap has increased by 31.26% in one year.
Market Cap
3.61B
Enterprise Value
11.03B
1-Year Change
31.26%
Ranking
Category
Stock Price
$13.74
ChartMarket Cap Chart
Since May 14, 2021, Organon & Co.'s market cap has decreased from $8.42B to $3.61B, a decrease of -57.14%. That is a compound annual growth rate of -14.61%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 23, 2026 | 3.61B | 93.50% |
| Dec 31, 2025 | 1.86B | -51.49% |
| Dec 31, 2024 | 3.84B | 4.25% |
| Dec 29, 2023 | 3.69B | -48.12% |
| Dec 30, 2022 | 7.10B | -7.98% |
| Dec 31, 2021 | 7.72B | -8.27% |
| May 14, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 259.31B |
| Amgen | 208.49B |
| Novo Nordisk | 191.02B |
| Gilead Sciences | 186.13B |
| Pfizer | 157.65B |
| Bristol-Myers Squibb Company | 128.81B |
| Sanofi | 101.74B |
| GSK plc | 100.62B |